Turn Therapeutics (TTRX) Equity Ratio (2024 - 2026)

Turn Therapeutics has reported Equity Ratio for 3 years, with the latest figure at 0.33 in Q1 2026.

• For the quarter ending Q1 2026, Equity Ratio changed N/A year-over-year to 0.33; the trailing twelve-month figure through Mar 2026 stood at 0.33 (changed N/A YoY), and the FY2025 full-year result was 0.39, up 544.98% from the prior year.
• Equity Ratio for Q1 2026 stood at 0.33, down from 0.39 in the prior quarter.
• The five-year high for Equity Ratio was 0.39 in Q4 2025, with the low at 0.09 in Q4 2024.
• Average Equity Ratio over 3 years is 0.19, with a median of 0.22 recorded in 2025.
• Peak annual rise in Equity Ratio reached 544.98% in 2025, while the deepest fall reached 544.98% in 2025.
• Tracing TTRX's Equity Ratio over 3 years: stood at 0.09 in 2024, then soared by 544.98% to 0.39 in 2025, then fell by 14.85% to 0.33 in 2026.
• The last three Equity Ratio figures came in at 0.33 (Q1 2026), 0.39 (Q4 2025), and 0.12 (Q3 2025), per Business Quant data.

Peer Comparison